A. Obermiller

11 Medical Management Options for Hepatocellular Carcinoma

M. Copur, A. Obermiller, 2017 .

Medical Management Options for Hepatocellular Carcinoma

M. Copur, A. Obermiller, 2012 .

Fulvestrant high dose vs. loading dose vs. approved dose: have we found the optimum dose?

M. Copur, A. Obermiller, 2011, Clinical breast cancer.

An algorithm for the management of hypertension in the setting of vascular endothelial growth factor signaling inhibition.

M. Copur, A. Obermiller, M. Sitki Copur, 2011, Clinical colorectal cancer.

Brief commentary: largest randomized trial of biliary tract cancer treatment with cisplatin plus gemcitabine versus gemcitabine alone: an excellent opportunity to evaluate the prognostic value of tumor marker CA 19-9.

M. Copur, A. Obermiller, 2011, Clinical colorectal cancer.

Efficacy and safety of half-dose pegfilgrastim in cancer patients receiving cytotoxic chemotherapy.

M. Copur, A. Obermiller, D. Nelson, 2012 .